Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002826.SZ Stock Summary
Top 10 Correlated ETFs
002826.SZ
In the News
002826.SZ Financial details
Company Rating
Buy
Market Cap
2.29B
Income
46.78M
Revenue
803.27M
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
0.83%
Employees
447
Optionable
No
Shortable
Yes
Earnings
28 Apr 2021
P/E
51.06
Forward P/E
-
PEG
-36.95
P/S
2.86
P/B
3.17
P/C
-
P/FCF
30.49
Quick Ratio
2.15
Current Ratio
2.4
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
0.19
EPS next Y
-
EPS next Q
-
EPS this Y
4.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.09%
Revenue last 5Y
11.88%
Revenue Q/Q
-21.04%
EPS Q/Q
-
-
-
-
-
SMA20
2.56%
SMA50
8.48%
SMA100
16.85%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
6%
ROC
0.07%
Gross Margin
47%
Oper. Margin
7%
Profit Margin
6%
Payout
44%
Shs Outstand
190.68M
Shs Float
163.58M
-
-
-
-
Target Price
-
52W Range
9.87-13.28
52W High
-7.54%
52W Low
+33.56%
RSI
44.47
Rel Volume
0.28
Avg Volume
10.23M
Volume
2.87M
Perf Week
-4.83%
Perf Month
2.04%
Perf Quarter
10.68%
Perf Half Y
7.8%
-
-
-
-
Beta
0.211
-
-
Volatility
0.24%, 0.28%
Prev Close
0.25%
Price
12.02
Change
-2.44%
002826.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.52 | 2.96 | 3.23 | 3.76 | 4.46 | |
Net income per share | 0.13 | 0.2 | 0.22 | 0.22 | 0.23 | |
Operating cash flow per share | 0.07 | 0.32 | 0.54 | 0.57 | 0.36 | |
Free cash flow per share | -0.28 | -0.6 | 0.34 | 0.44 | 0.34 | |
Cash per share | 1.23 | 1.02 | 1.1 | 0.95 | 1.67 | |
Book value per share | 3.18 | 3.49 | 3.68 | 3.72 | 3.88 | |
Tangible book value per share | 2.91 | 3.2 | 3.4 | 3.35 | 3.56 | |
Share holders equity per share | 3.18 | 3.49 | 3.68 | 3.72 | 3.88 | |
Interest debt per share | 0.21 | 0.39 | 0.22 | 0 | 0.27 | |
Market cap | 1.94B | 1.89B | 1.82B | 2.11B | 1.96B | |
Enterprise value | 1.74B | 1.8B | 1.66B | 1.93B | 1.68B | |
P/E ratio | 76.73 | 50.55 | 44.36 | 49.77 | 44.3 | |
Price to sales ratio | 3.96 | 3.41 | 3.03 | 2.91 | 2.28 | |
POCF ratio | 145.55 | 31.87 | 17.92 | 19.3 | 28.57 | |
PFCF ratio | -35.62 | -16.96 | 28.8 | 25.07 | 29.97 | |
P/B Ratio | 3.13 | 2.89 | 2.65 | 2.95 | 2.62 | |
PTB ratio | 3.13 | 2.89 | 2.65 | 2.95 | 2.62 | |
EV to sales | 3.56 | 3.25 | 2.75 | 2.66 | 1.97 | |
Enterprise value over EBITDA | 42.92 | 29.96 | 24.53 | 27.37 | 20.12 | |
EV to operating cash flow | 130.63 | 30.35 | 16.29 | 17.64 | 24.6 | |
EV to free cash flow | -31.97 | -16.15 | 26.18 | 22.9 | 25.81 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
Free cash flow yield | -0.03 | -0.06 | 0.03 | 0.04 | 0.03 | |
Debt to equity | 0.06 | 0.11 | 0.06 | 0 | 0.07 | |
Debt to assets | 0.05 | 0.08 | 0.04 | 0 | 0.05 | |
Net debt to EBITDA | -4.9 | -1.5 | -2.45 | -2.59 | -3.24 | |
Current ratio | 3.37 | 2.22 | 2.06 | 3.65 | 2.2 | |
Interest coverage | 19.46 | 17.61 | 26.67 | 57.69 | 68.75 | |
Income quality | 0.53 | 1.59 | 2.48 | 2.52 | 1.48 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.51 | 0.23 | 0.23 | 0.38 | 0.45 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | |
Research and developement to revenue | 0.03 | 0.01 | 0.01 | 0.02 | 0.02 | |
Intangibles to total assets | 0.07 | 0.07 | 0.06 | 0.09 | 0.07 | |
Capex to operating cash flow | -5.09 | -2.88 | -0.38 | -0.23 | -0.05 | |
Capex to revenue | -0.14 | -0.31 | -0.06 | -0.03 | 0 | |
Capex to depreciation | -7.15 | -15.62 | -2.3 | -1.06 | -0.14 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.05 | 3.97 | 4.27 | 4.29 | 4.48 | |
ROIC | 0.04 | 0.05 | 0.05 | 0.06 | 0.06 | |
Return on tangible assets | 0.04 | 0.05 | 0.05 | 0.06 | 0.05 | |
Graham Net | 1.34 | 0.81 | 0.87 | 1.04 | 1.21 | |
Working capital | 326.56M | 220.26M | 231.98M | 262.83M | 313.1M | |
Tangible asset value | 564.54M | 597.56M | 635.87M | 646.39M | 682.42M | |
Net current asset value | 324.68M | 217.33M | 229.31M | 257.81M | 306.8M | |
Invested capital | 0.06 | 0.11 | 0.06 | 0 | 0.07 | |
Average receivables | 189.03M | 184.44M | 198.69M | 182.9M | 174.96M | |
Average payables | 9.69M | 19.09M | 33.08M | 28.2M | 72.11M | |
Average inventory | 31.42M | 29.13M | 25.15M | 27.15M | 39.58M | |
Days sales outstanding | 145.95 | 114.42 | 135.64 | 71.37 | 88.64 | |
Days payables outstanding | 12.32 | 26.53 | 37.07 | 13.5 | 96.47 | |
Days of inventory on hand | 31.45 | 29.13 | 19.58 | 26.38 | 34.6 | |
Receivables turnover | 2.5 | 3.19 | 2.69 | 5.11 | 4.12 | |
Payables turnover | 29.64 | 13.76 | 9.85 | 27.03 | 3.78 | |
Inventory turnover | 11.61 | 12.53 | 18.64 | 13.83 | 10.55 | |
ROE | 0.04 | 0.06 | 0.06 | 0.06 | 0.06 | |
Capex per share | -0.35 | -0.91 | -0.21 | -0.13 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.97 | 1.38 | 0.82 | 1.06 | 0 | |
Net income per share | 0.04 | 0.12 | 0.04 | 0.03 | 0 | |
Operating cash flow per share | 0.04 | 0.12 | 0.04 | 0.24 | 0 | |
Free cash flow per share | 0.04 | 0.11 | 0.04 | 0.24 | 0 | |
Cash per share | 1.41 | 1.67 | 1.69 | 1.85 | 0 | |
Book value per share | 3.38 | 3.88 | 3.6 | 3.95 | 0 | |
Tangible book value per share | 3.07 | 3.56 | 3.31 | 3.64 | 0 | |
Share holders equity per share | 3.38 | 3.88 | 3.6 | 3.95 | 0 | |
Interest debt per share | 0.24 | 0.26 | 0.24 | 0.26 | 0 | |
Market cap | 2.04B | 1.96B | 2.25B | 2.13B | 0 | |
Enterprise value | 1.89B | 1.68B | 2.05B | 1.97B | -217.59M | |
P/E ratio | 55.08 | 21.36 | 67.25 | 93.02 | 0 | |
Price to sales ratio | 9.91 | 7.38 | 13.12 | 10.38 | 0 | |
POCF ratio | 220.3 | 85.43 | 269 | 46.01 | 0 | |
PFCF ratio | 227.48 | 89.19 | 276.26 | 46.33 | 0 | |
P/B Ratio | 2.84 | 2.62 | 2.99 | 2.79 | 0 | |
PTB ratio | 2.84 | 2.62 | 2.99 | 2.79 | 0 | |
EV to sales | 9.18 | 6.36 | 11.94 | 9.61 | -1.34 | |
Enterprise value over EBITDA | 156.37 | 52.29 | 220.12 | 328.95 | -16.23 | |
EV to operating cash flow | 204.03 | 73.58 | 244.81 | 42.63 | -5.14K | |
EV to free cash flow | 210.68 | 76.82 | 251.41 | 42.92 | 385.71 | |
Earnings yield | 0 | 0.01 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0.01 | 0 | 0.02 | 0 | |
Debt to equity | 0.07 | 0.07 | 0.07 | 0.07 | 0.01 | |
Debt to assets | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | |
Net debt to EBITDA | -12.47 | -8.42 | -21.75 | -26.14 | -16.23 | |
Current ratio | 2.45 | 2.2 | 2.33 | 2.25 | 2.4 | |
Interest coverage | 42.02 | 51.21 | 26.02 | 15.79 | 54.62 | |
Income quality | 1 | 1 | 1 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0.02 | 0.06 | 0.08 | 1.96 | |
Sales general and administrative to revenue | 0.11 | -0.02 | 0.06 | 0.02 | 0.17 | |
Research and developement to revenue | 0 | 0.04 | 0 | 0.03 | 0.03 | |
Intangibles to total assets | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | |
Capex to operating cash flow | -0.03 | -0.04 | -0.03 | -0.01 | -14.33 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.82 | 3.23 | 1.8 | 1.62 | 0 | |
ROIC | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | 1.04 | 1.21 | 1.21 | 1.22 | 0 | |
Working capital | 281.62M | 313.1M | 330.42M | 306.34M | 303.56M | |
Tangible asset value | 653.96M | 682.42M | 692.3M | 703.21M | 695.71M | |
Net current asset value | 277M | 306.8M | 321.3M | 297.43M | 294.86M | |
Invested capital | 0.07 | 0.07 | 0.07 | 0.07 | 0.01 | |
Average receivables | 141.34M | 173.34M | 194.86M | 163.02M | 155.85M | |
Average payables | 54.81M | 95.91M | 121.75M | 123.88M | 140.06M | |
Average inventory | 35.74M | 39.1M | 44.76M | 47.47M | 52.86M | |
Days sales outstanding | 60.55 | 70.67 | 95.37 | 63.38 | 93.04 | |
Days payables outstanding | 51.65 | 76.28 | 109.83 | 106.19 | 194.84 | |
Days of inventory on hand | 26.02 | 27.36 | 41.44 | 41.24 | 71.64 | |
Receivables turnover | 1.49 | 1.27 | 0.94 | 1.42 | 0.97 | |
Payables turnover | 1.74 | 1.18 | 0.82 | 0.85 | 0.46 | |
Inventory turnover | 3.46 | 3.29 | 2.17 | 2.18 | 1.26 | |
ROE | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | |
Capex per share | 0 | -0.01 | 0 | 0 | 0 |
002826.SZ Frequently Asked Questions
What is Tibet AIM Pharm. Inc. stock symbol ?
Tibet AIM Pharm. Inc. is a CN stock and trading under the symbol 002826.SZ
What is Tibet AIM Pharm. Inc. stock quote today ?
Tibet AIM Pharm. Inc. stock price is $12.02 today.
Is Tibet AIM Pharm. Inc. stock public?
Yes, Tibet AIM Pharm. Inc. is a publicly traded company.